AnTolRx, Inc. — Form D
AnTolRx, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-12. The offering totals $4.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-07-12
- Form: D
- Accession: 0001679154-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.0M
- Remaining: $3.0M
- Investors: 3
- Date of first sale: 2016-06-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-266826
Issuer
- Name: AnTolRx, Inc.
- CIK: 0001679154
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: THE PILOT HOUSE, 6TH FLOOR, BOSTON, MA, 02110
- Phone: 617-297-2450
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Mark Carthy | Director | Cambridge, MA |
| Satish Jindal | Director | Cleveland, OH |
| Francisco Quintana | Director | Boston, MA |
| Mark Carthy | Executive Officer | Cambridge, MA |
More